A few studies have exemplified that the expression of the circadian clock gene Per2 is markedly downregulated in non-small cell lung cancer, breast cancer, ovarian cancer, gastric cancer, colorectal cancer and liver cancer 17-19, 22, 23, and it is tightly connected to the occurrence and development of cancer. Here, PER2 is linked to ovarian carcinoma.